Reviva Pharmaceuticals Holdings, Debt 2024

Reviva Pharmaceuticals Holdings, Debt

-18.52 USD

Reviva Pharmaceuticals Holdings, Dividend yield

Ticker

RVPH

ISIN

US76152G1004

In 2024, Reviva Pharmaceuticals Holdings,'s total debt was -18.52 USD, a -37.62% change from the -29.69 USD total debt recorded in the previous year.

Reviva Pharmaceuticals Holdings, Aktienanalyse

What does Reviva Pharmaceuticals Holdings, do?

Reviva Pharmaceuticals Holdings, ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Reviva Pharmaceuticals Holdings,'s Debt Structure

Reviva Pharmaceuticals Holdings,'s total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Reviva Pharmaceuticals Holdings,'s debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Reviva Pharmaceuticals Holdings,’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Reviva Pharmaceuticals Holdings,’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Reviva Pharmaceuticals Holdings, Stock

What is the debt of Reviva Pharmaceuticals Holdings, this year?

Reviva Pharmaceuticals Holdings, has a debt level of -18.52 USD this year.

What was the debt of Reviva Pharmaceuticals Holdings, compared to the previous year?

The debt of Reviva Pharmaceuticals Holdings, has increased by -37.62% compared to the previous year dropped.

What are the consequences of high debt for investors in Reviva Pharmaceuticals Holdings,?

High debt can pose a risk for investors of Reviva Pharmaceuticals Holdings,, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Reviva Pharmaceuticals Holdings,?

Low debt means that Reviva Pharmaceuticals Holdings, has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Reviva Pharmaceuticals Holdings, affect the company?

An increase in debt of Reviva Pharmaceuticals Holdings, can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Reviva Pharmaceuticals Holdings, affect the company?

A reduction in debt of Reviva Pharmaceuticals Holdings, can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Reviva Pharmaceuticals Holdings,?

Some factors that can influence the debt of Reviva Pharmaceuticals Holdings, include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Reviva Pharmaceuticals Holdings, so important for investors?

The debts of Reviva Pharmaceuticals Holdings, are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Reviva Pharmaceuticals Holdings, take to change the debt?

To change the debt, Reviva Pharmaceuticals Holdings, can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Reviva Pharmaceuticals Holdings, pay?

Over the past 12 months, Reviva Pharmaceuticals Holdings, paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Reviva Pharmaceuticals Holdings, is expected to pay a dividend of 0 USD.

What is the dividend yield of Reviva Pharmaceuticals Holdings,?

The current dividend yield of Reviva Pharmaceuticals Holdings, is .

When does Reviva Pharmaceuticals Holdings, pay dividends?

Reviva Pharmaceuticals Holdings, pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Reviva Pharmaceuticals Holdings,?

Reviva Pharmaceuticals Holdings, paid dividends every year for the past 0 years.

What is the dividend of Reviva Pharmaceuticals Holdings,?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Reviva Pharmaceuticals Holdings, located?

Reviva Pharmaceuticals Holdings, is assigned to the 'Health' sector.

Wann musste ich die Aktien von Reviva Pharmaceuticals Holdings, kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Reviva Pharmaceuticals Holdings, from 6/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/2/2024.

When did Reviva Pharmaceuticals Holdings, pay the last dividend?

The last dividend was paid out on 6/2/2024.

What was the dividend of Reviva Pharmaceuticals Holdings, in the year 2023?

In the year 2023, Reviva Pharmaceuticals Holdings, distributed 0 USD as dividends.

In which currency does Reviva Pharmaceuticals Holdings, pay out the dividend?

The dividends of Reviva Pharmaceuticals Holdings, are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Reviva Pharmaceuticals Holdings,

Our stock analysis for Reviva Pharmaceuticals Holdings, Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Reviva Pharmaceuticals Holdings, Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.